Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6

This study has been completed.
United States Agency for International Development (USAID)
Information provided by:
University of Oxford Identifier:
First received: September 13, 2005
Last updated: October 27, 2005
Last verified: February 2005
Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.

Condition Intervention Phase
Village Children
Drug: Vitamin A
Drug: Albendazole
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Deworming and Enhanced Vitamin A Supplementation DEVTA Project

Resource links provided by NLM:

Further study details as provided by University of Oxford:

Primary Outcome Measures:
  • childhood mortality rate at age 1-6

Secondary Outcome Measures:
  • fecal egg counts, plasma retinal, growth, sign of Vitamin A deficiency

Estimated Enrollment: 720000
Study Start Date: January 1999
Estimated Study Completion Date: February 2005

Ages Eligible for Study:   1 Year to 6 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes


  • Area of residence

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00222547

Shally Awasthi
Lucknow, Uttar Pradesh, India, UP226 003
Sponsors and Collaborators
University of Oxford
United States Agency for International Development (USAID)
Study Chair: Shally Awasthi, MD King George Medical University, Lucknow
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00222547     History of Changes
Other Study ID Numbers: DEVTA 
Study First Received: September 13, 2005
Last Updated: October 27, 2005
Health Authority: India: Institutional Review Board

Additional relevant MeSH terms:
Retinol palmitate
Vitamin A
Anticarcinogenic Agents
Antineoplastic Agents
Growth Substances
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Protective Agents processed this record on May 26, 2016